Type 1 diabetes (T1D), specifically, is an autoimmune disorder marked by little to no insulin production and secretion due to the attack and loss of cells by autoreactive T cells
However, tirzepatide is not FDA-approved for treating MASLD, and any such use would be considered off-label
In addition to their peripheral actions, GLP-1Rs are also expressed throughout the central nervous system, particularly within hypothalamic nuclei, septal regions, the brainstem and at lower levels in various cortical structures (Pyke et al., 2014
It is a research chemical not approved for human use
It is used together with a reduced-calorie diet and increased physical activity for weight loss and to help keep the weight under control in adults who have: a BMI of 30 kg/m or greater (obesity) or a BMI of at least 27 kg/m but less than 30 kg/m (overweight) and weight-related health problems (such as prediabetes, type 2 diabetes, high blood pressure, abnormal levels of fats in the blood, breathing problems during sleep called obstructive sleep apnoea (OSA) or a history of heart attack, stroke or blood vessel problems)